News
Atai Life Sciences NV shares climbed after a psychedelic nasal spray from Beckley Psytech Ltd, the company it plans to ...
21h
PsyPost on MSNPsychedelic compound blurs boundary between self and others in the brain, study findsA recent study found that a DMT/harmine formulation blurs the brain’s distinction between self and other faces, disrupting ...
1d
Clinical Trials Arena on MSNatai and Beckley Psytech’s psychedelic wins in Phase IIb depression trialThe companies are also running an open-label study to evaluate the long-term efficacy and safety of the therapy.
An experimental psychedelic therapy from the U.K. company Beckley Psytech significantly reduced symptoms of ...
With more and more data showing the efficacy of psychedelic treatments for PTSD and other mental health condiditions, there ...
Shares of atai Life Sciences (NASDAQ:ATAI) traded higher in the premarket on Tuesday after the company and its partner, ...
BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...
Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray ...
The government has permitted Dr. Cameron Lacey, a psychiatrist, to prescribe psilocybin, a hallucinogenic compound found in ...
The Acid Queen’ and ‘The Last Great Dream’ chart the characters and consequences of the counterculture — and its continuing ...
A veteran advocating for the bill said psilocybin improved his PTSD symptoms after VA therapies failed to provide relief.
Colorado policymakers, including Gov. Jared Polis and Attorney General Phil Weiser, expressed enthusiasm about the potential ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results